Bill of Rights for individuals with primary immunodeficiencies
January 25, 2024
View PDF
Addressing accessibility of gene and cell therapies
January 24, 2024
View PDF
Parents push Medicaid to cover four-year-old’s thymus tissue implant
January 23, 2024
Read article
2023 Community Impact flyer
January 16, 2024
View PDF
Mast cell activation disease diagnosis can reveal PI
January 13, 2024
Read article
COVID update stresses the importance of knowing individual risk
December 20, 2023
Read article
COVID's impact on the PI community
December 19, 2023
Watch video
Undiagnosed (feat. Dr. Kelley Hagerich): Two different traumas
December 19, 2023
Listen to podcast
Plasma donor since 2008, Victoria Picone exceeds 1500 donations
December 19, 2023
Read article
Alyglo
Administration: IVIG
Concentration: 10% (100 mg/mL)
Approved for: Ages 17+
Report side effects/adverse reactions at medicalinfo@gcbiopharmausa.com or 1-833-426-6426.
